Five things for pharma marketers to know: Friday, December 4, 2020
COVID-19 numbers hit new highs in the U.S.; CVS launches pilot antibody treatment program; HHS lays out a road map to improved maternal health.
HHS
What the government’s COVID-19 vaccination campaign will look like
The federal government and the private sector will have their work cut out for them encouraging people to get the vaccine, and telling them how to do so.
HHS to go ahead with $250m ‘defeat despair’ COVID-19 campaign, but without celebrities
The push was put on hold last month after HHS Secretary Alex Azar called for its review.
Stalled HHS coronavirus ad campaign sought to capitalize on star power, but public-health push came too late
The Department of Health and Human Services drafted public health officials and celebs to push a “defeat despair” message. But if this qualifies as an embrace of science, it’s too late.
‘America has no one left to trust:’ Former HHS comms staffers on COVID-19 report meddling
“You don’t renegotiate a bible when you teach it,” says one ex-HHS official.
Fors Marsh Group wins $250m-plus HHS contract for campaign to ‘defeat despair’
The federal department asked bidding firms to craft a campaign that would “inspire hope” amid the pandemic. Critics worry it could be politicized.
‘He knew more about comms than I did about epidemiology.’ Former HHS press secretary on efforts to sideline Fauci and the way forward
Communicators inside the White House would do well to stop maligning public health experts, for the sake of the country and their own credibility, says a former HHS press officer.
Five things for pharma marketers to know: Thursday, July 16, 2020
HHS to receive COVID-19 patient data; Radiation may help speed recovery from coronavirus-related pneumonia; Podcast: WebMD’s Dr. John Whyte.
Appeals court strikes down the rule requiring list prices in drug ads, again
A previous judge ruled that HHS did not have the authority to issue the rule.
Telehealth rules relaxed, but patients still face barriers
The government has relaxed telehealth rules as most people stay home to help flatten the curve, but patients still face barriers for virtual visits.
